治疗先天性代谢缺陷的医疗食品市场规模预计2021年为29.8亿美元,2023年为XX亿美元,预计到2031年将达到97.6亿美元;预计到 2031 年,复合年增长率将达到 13.4%。不断增长的在线分销平台可能仍然是先天性代谢缺陷医疗食品市场趋势的关键。
针对先天性代谢缺陷的医疗食品市场分析
先天性代谢缺陷是指编码代谢功能蛋白质的基因突变导致的遗传性疾病。先天性代谢缺陷是一组异质性疾病,很可能通过自发突变遗传。这些疾病通常涉及代谢途径的失败,这些途径涉及碳水化合物、蛋白质和脂肪酸等生物分子的分解或储存。根据国家生物技术信息中心 (NCBI) 2023 年 7 月的数据,2,500 名新生儿中就有 1 人患有先天性缺陷,这使得先天性缺陷在世界各地非常普遍。一些常见的先天性代谢缺陷包括苯丙酮尿症 (PKU)、枫糖浆尿病、半乳糖血症和果糖不耐受。针对先天性代谢缺陷的医疗食品可作为摄取、消化、吸收或代谢普通食物或营养素的能力有限或受损的患者的营养治疗。因此,全球这些疾病发病率的增加预计将增加对先天性代谢缺陷的医疗食品的需求,从而支持市场增长。
针对先天性代谢缺陷的医疗食品市场概述
北美是先天性代谢缺陷医疗食品市场的最大市场,其中美国占有最大的市场份额,其次是加拿大。美国市场的增长是由先天性代谢错误患病率上升、新生儿筛查增加以及针对各种代谢错误的各种医疗食品的供应等因素推动的。同样,在加拿大,越来越多的政府举措提高了人们对罕见遗传疾病的认识,以及完善的医疗基础设施正在导致市场增长。
定制研究以满足您的要求
我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
针对先天性代谢缺陷市场的医疗食品:
市场规模 价值 | 2019年25.078亿美元 |
市场规模价值 | 到 2027 年将达到 57.6879 亿美元 |
增长率 | 2020-2027 年复合年增长率为 11.2% |
预测期 | 2020-2027 |
基准年 | 2020年 |
阿克谢
针对先天性代谢缺陷的医疗食品市场驱动因素和机遇
政府为提高人们对先天性代谢缺陷的认识而采取的举措和计划,以利于市场
澳大利亚政府启动了先天性代谢缺陷 (IEM) 计划,该计划旨在帮助那些在分解食物中的蛋白质方面存在问题的个人和家庭。他们需要特殊的饮食,IEM 计划可以帮助他们支付特殊食物的费用。这项举措很重要,因为 IEM 患者需要低蛋白、高脂肪和不含苯丙氨酸的饮食。这些食物非常昂贵。这些钱用来购买这些食物,这样他们就能保持节食并保持健康。因此,政府不断采取此类举措来提高人们对先天性代谢缺陷的认识,是全球先天性代谢缺陷市场份额的主要驱动因素。
全球发展医疗保健产业——机遇
过去几年,医疗保健行业经历了快速转型。全球各国都青睐易于使用且有效的医疗保健先进解决方案。由于需要更好的医疗保健设施,技术支持的护理 (TEC) 解决方案在新兴经济体的医疗保健系统中受到青睐。人口老龄化的增加、慢性病的发病率、儿科护理的缺乏以及遗传性疾病可能是推动医疗保健行业增长的主要因素。
该行业的各个老牌企业一直将大量收入投入研发活动,以开发更好、更先进的解决方案,以满足客户日益增长的需求。此外,近年来各种医疗食品报销的增加预计将推动该行业在未来几年的增长。根据政府机构制定的法规,可以获得更好、更可靠的健康管理解决方案,确保优质护理、患者安全和疾病管理。 例如,2023 年 7 月,美国食品药品监督管理局 (FDA) 发布了行业指南修订草案,内容涉及药品开发临床试验中的饮食优化和标准化。该指南的标题是“使用饮食管理的先天性代谢错误:药品开发临床试验中优化和标准化饮食的注意事项”。该指南列出了 FDA 目前关于开发治疗先天性代谢错误 (IEM) 药物产品的建议,其中饮食管理是患者代谢控制的重要组成部分。 FDA 认为,在临床试验之前和期间优化和标准化这些患者的饮食管理对于确保准确评估新药产品的功效至关重要。人们越来越关注预防性健康,并采用简单的治疗方案,例如医疗食品和营养补充剂来管理出生期间获得的各种代谢相关疾病,这可能为未来几年市场的增长提供机会。
针对先天性代谢缺陷的医疗食品市场报告细分分析
有助于推导代谢市场分析中先天性缺陷医疗食品的关键部分是产品、年龄组、疾病、形式、包装、分销渠道。
- 根据产品,先天性代谢缺陷市场的医疗食品分为氨基酸、GMP 甘肽、含铁氨基酸改良婴儿配方奶粉、低钙/无维生素 D 含铁婴儿配方奶粉、低蛋白食品等。 2023 年,氨基酸细分市场占据最大市场份额。
- 按年龄组划分,市场分为婴儿、断奶者、青少年、成人。 2023 年,婴儿细分市场占据最大市场份额。
- 就疾病而言,市场分为苯丙酮尿症(PKU)、枫糖浆尿病(MSUD)、同型半胱氨酸尿症、尿素循环障碍、甲基丙二酸血症、有机酸尿症、丙酸血症、异戊酸血症、亮氨酸代谢障碍、I型戊二酸血症、肾脏疾病、酪氨酸血症 I 型和 II 型、其他)。 2023 年,PKU 细分市场占据市场主导地位。
- 就形式而言,市场分为粉末、液体、凝胶等。 2023 年,粉末细分市场将占据市场主导地位。
- 就包装而言,市场分为罐装、罐装、袋装、瓶装等。罐头细分市场在 2023 年占据市场主导地位。
- 从分销渠道来看,市场分为零售药店、医院药房、网上药店、药店等。 2023 年,医院药房领域占据市场主导地位。
针对先天性代谢缺陷的医疗食品市场份额分析(按地理位置)
先天性代谢缺陷医疗食品市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲、南美洲/南美洲和中美洲。
北美在治疗先天性代谢缺陷的医疗食品市场上占据主导地位。美国治疗先天性代谢缺陷(IEM)的医疗食品市场在北美国家中占有最大份额。该国的多个政府机构正在致力于制定 IEM 管理的综合指南。例如,2023 年 12 月,FDA 宣布成立一个新的咨询委员会,重点研究遗传代谢疾病的潜在治疗方法。该委员会称为遗传代谢疾病咨询委员会,将就与遗传代谢疾病医疗产品有关的技术、科学和政策问题向 FDA 提供独立且知识渊博的意见和建议。委员会成员将评估与提交给他们的申请相关的证据,并提供建议供 FDA 考虑。该委员会将由先天性代谢缺陷管理、代谢遗传学、小群体试验设计、流行病学、统计学、转化科学、儿科和其他相关专业领域的专家组成。预计亚太地区未来几年将以最高的复合年增长率增长。
针对先天性代谢缺陷的医疗食品市场报告范围
针对先天性代谢缺陷的医疗食品市场新闻和最新动态
通过收集初级和二级研究后的定性和定量数据来评估代谢市场先天性错误的医疗食品,其中包括重要的企业出版物、协会数据和数据库。以下是治疗先天性代谢缺陷的医疗食品市场的发展情况:
- 2022 年 10 月,Galen 在英国市场推出了 TYR EASY 片剂,这是第一个治疗酪氨酸血症的固体剂量蛋白质替代品。这些片剂专为支持 8 岁以上酪氨酸血症 (TYR) 患者的饮食管理而设计,为他们提供更多最适合其日常需求的蛋白质替代品选择。 (来源:Galen,新闻稿,2022 年)
- 2021 年 12 月,SFI Health 宣布在美国推出两种新的医疗食品:EQUAZEN PRO 和 Ther-Biotic PRO IBS Relief。这两种医疗食品均采用经过临床验证的成分制成,并经过临床研究的广泛测试,以评估其安全性和有效性。 EQUAZEN® PRO 有助于重新平衡欧米伽脂肪酸水平,同时支持健康的脂肪酸代谢。 (来源:SFI Health,新闻稿/公司网站/时事通讯,2021 年)
针对先天性代谢缺陷的医疗食品市场报告范围和交付成果
《先天性代谢缺陷医疗食品市场规模和预测(2021-2031)》报告对以下领域的市场进行了详细分析:
- 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,例如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.